{"name":"Stalicla SA","slug":"stalicla-sa","ticker":"","exchange":"","domain":"stalicla.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPRm5Bd1FrUzllRmF6b3FWTUQ4Rm5OaUNzYU5zYTFSV0gtWVNISXRmeE9zYUJLU2taaWlBVUw5RFNhTU8wRFBSWUptN0J3eEJ1Qm9aZ1RRMmFkTDNCSW1ISXdHR0x0MlZKMlZZZE92S2tsS09ndnF0RFEzUm51MlBMSXNKYUZLbDR1MWUtSV9VclpYdzFhUGhuWS04VEFkREhoWkNfQWp0bnBWSFJubEF6MllQOGxPWk1aTHljX2hHZFFlUDFCb3RUb2RxMXptVnhxV1FaVU8zYTdvMXpLUW5ZX2dBSFNicHRSVGxlSWpEQQ?oc=5","date":"2025-02-13","type":"pipeline","source":"BioSpace","summary":"Autism Spectrum Disorder Markets Expected to Exhibit a CAGR Of 5.84% During 2025-2035, impelled by Innovative Treatments - BioSpace","headline":"Autism Spectrum Disorder Markets Expected to Exhibit a CAGR Of 5.84% During 2025-2035, impelled by Innovative Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgJBVV95cUxOYUJKaG5ZZk4xakNndFIxZlI4dTJ5aUp4UkUxZEp3TFFxdFVPSmNibUhVR25TRGFfSDBPd1ZVRzRsb3JFTUVaVWxiMHlyNWhFS2dyeG5STm5GdFpZR0cyb0l4T0RWYzJGbnYzMjEwd0t4ZElJVTN3aGhIUzh5dzFlQ1pNRWhPV2FSYlE4NVpSczFHX2JYaEJUYi10aFJRWEZyS0ZTUjZSZUtTSDhvT3NURmlqcmY2bVNiWnFON0ZQTkwzOWs4SmRXbGZKWGZHaERuUU1HRXpaQUUyY0xRRThUQkkyaGNlT01DZVlHb3JxT1JTbzhfSGJTM2NCUWVObWlScm15R2VtQ2FjVHN3LXpydG5qZF9iUWFoeXExa21rN0djcVRhSGZVNGtqa1hkMV9NdUlJMzJoRjV1dS1TMi1pbk5FY0RnQQ?oc=5","date":"2024-07-04","type":"pipeline","source":"prnewswire.com","summary":"Autism Spectrum Disorder Therapeutics Market size is set to grow by USD 766.1 million from 2024-2028, Increasing prevalence of asd to boost the market growth, Technavio - prnewswire.com","headline":"Autism Spectrum Disorder Therapeutics Market size is set to grow by USD 766.1 million from 2024-2028, Increasing prevale","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQMXQ0OUwtUXl3TFp4X1RUdE9RSVctSXZlbEVTUHM0SDFaSjhHd00wXzdMLUNKVWxEb2dwNnVNeTViVm1XWTJVWDRZdFNmQUc2NWRpVmFhNEs3WHBXQkliWXlMWlduaXlwOHBYTGJSeFFwT2RTd1l4ZmRncG5TUGxJblFwSVByR0JmRmliX19FNG95dUh6YlRFbTFIM0wtTW8?oc=5","date":"2024-04-11","type":"pipeline","source":"businesswire.com","summary":"STALICLA Appoints Dr. Thomas Blaettler, MD - businesswire.com","headline":"STALICLA Appoints Dr. Thomas Blaettler, MD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ3BZTFZjQ2wzTzYzQWt0b1FXOVpVcWoxNWdrZjJ5MnNQak83ZjJIanNxSkdjdUdpVko0dGNlMDlPd2RXOHRxZjJrNkNSOEg2RUh4WkJKM2s1bnU5emRiMFNiMHRzek5EZzU2ejZMUmhldy1xVU9ueFRMNmRpTGlRSGotSGVyLS04UkowR2NJQ2d1bmVBd2o5U1FqYUthbFJJdTROSlFB?oc=5","date":"2023-01-08","type":"deal","source":"Citeline News & Insights","summary":"Stalicla Seals Deal To Advance Novartis Drug For Cocaine Misuse - Citeline News & Insights","headline":"Stalicla Seals Deal To Advance Novartis Drug For Cocaine Misuse - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOZXFoUm1ZN01faTZsRDY1OW5ISEE2MVQtVU5yNDA0aVlaNzBOY1Z5OVJ0UUl3eUwzdXFSN29XWUtYVVJlSXBMT3JvZ1BLZFVHSFNRWkNkMW92ZzRZUHY2ZC1MS0lPZGhOMWNja1FvYXJZOVY5R3dmMnNSdGN5QU9BanJ2TQ?oc=5","date":"2022-10-11","type":"deal","source":"Pharmaceutical Technology","summary":"Stalicla signs licence deal for Evgen Pharma’s lead asset SFX-01 - Pharmaceutical Technology","headline":"Stalicla signs licence deal for Evgen Pharma’s lead asset SFX-01","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNSG1JRm9UNE1NczhLN3k4eVFIM0NsZjVLcDJ3cndlQTJGanhad3hjQTFuU3MtRUFiR1MzUFo5YWtGc0FScWoxSzJfeTJsLXBYNGZZd05EYUszY1FQNGxUa2ZxOXY3SV8wQUhld2tldmhyY3E1SXY0NmY1cmxqM3dQSTBZRm1HWW9ELThfQ1k4enRycnVwVk9GZHpsU2RNNnlHcWI1ME1OTFZfTUVkVEIwYk5FY053M0pUaTQtNEFLX0FHcjhO?oc=5","date":"2022-10-11","type":"pipeline","source":"startupticker.ch","summary":"STALICLA strengthens pipeline to advance precision medicine for Autism Spectrum Disorders - startupticker.ch","headline":"STALICLA strengthens pipeline to advance precision medicine for Autism Spectrum Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxPcDRpaUh0eHNMSEZrNEZmWmdYd3FycHBybldKVjFwaDVoWGY4MzVhS3I5MmQ5NV9fQmVNb0liT0FZODM3SXE2WFRsdEF1dFR5amFTQXF1RmtGYmFiQjFiV1Y4THF3LVBHWEtLaVVRdFFtT3JHOFF4aU52cFpqSXZtaWpxXy1EelhGR3dRUjRxbHpjd1JxRFRHS2pJaUNTeG9GbVZUZHlORG80c1pPSmpRTWh4UDBiTGdnMzBQNjdRMlNFd09OcWJlek5n?oc=5","date":"2021-05-11","type":"pipeline","source":"businesswire.com","summary":"STALICLA Appoints Baltazar Gomez-Mancilla, MD, PhD, as Chief Medical Officer - businesswire.com","headline":"STALICLA Appoints Baltazar Gomez-Mancilla, MD, PhD, as Chief Medical Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}